AND PRODUCT SUPPLY
Grounded in excellence and driven by innovation, our Industrial Operations and Product Supply (IOPS) team is responsible for the production of Regeneron products.
IOPS successfully manufactures a range of biopharmaceuticals for patients worldwide, including our approved therapeutic proteins and those involved in clinical studies.
Our operations follow strict adherence to current Good Manufacturing Practices (cGMP) and use cutting-edge analytical equipment, automated laboratory information management systems and electronic document management systems, all of which are supported by an extensive calibration, validation and preventive maintenance program. Our independent clean-room suites with ultra-modern clean utilities support both single-use and stainless steel cell culture bioreactors and large-scale chromatography systems designed to produce and purify our product candidates.
Supported by a highly skilled team of scientists, engineers, biotech production specialists and managers, our integrated teams bring an unsurpassed expertise in developing, operating, optimizing, validating and licensing the complex manufacturing processes required for production of biopharmaceuticals.
We embrace our role — and the immense responsibility it carries — to produce the highest-quality medicines for patients as efficiently as possible.
THE SHINGO PRIZE FOR OPERATIONAL EXCELLENCE
In 2019, Industrial Operations and Product Supply (IOPS) Rensselaer was recognized by the Shingo Institute with their highest award, the prestigious Shingo Prize, for operational excellence. Learn how we challenge the status-quo and foster a culture where continuous improvement is not just a metric— it's a mindset for everyone, every day to do better.